[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.166.74.94. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
March 11, 1998

Antibiotic Therapy for Premature Rupture of Membranes to Prevent Respiratory Distress Syndrome

Author Affiliations
 

Margaret A.WinkerMD, Senior EditorIndividualAuthorPhil B.FontanarosaMD, Senior EditorIndividualAuthor

JAMA. 1998;279(10):748-749. doi:10-1001/pubs.JAMA-ISSN-0098-7484-279-10-jac80000

To the Editor.—Dr Mercer and colleagues of the National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network1 have recently recommended that women with expectantly managed preterm premature rupture of membranes (PPROM) remote from term (≤32 weeks) should receive a specific regimen of antimicrobials to reduce infant morbidity. Whereas we applaud their efforts, we cannot agree that the conclusion should necessarily follow from their results given contemporary perinatal practice.

First Page Preview View Large
First page PDF preview
First page PDF preview
×